AU2021226507A1 - Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition - Google Patents

Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition Download PDF

Info

Publication number
AU2021226507A1
AU2021226507A1 AU2021226507A AU2021226507A AU2021226507A1 AU 2021226507 A1 AU2021226507 A1 AU 2021226507A1 AU 2021226507 A AU2021226507 A AU 2021226507A AU 2021226507 A AU2021226507 A AU 2021226507A AU 2021226507 A1 AU2021226507 A1 AU 2021226507A1
Authority
AU
Australia
Prior art keywords
cells
hematopoietic
stem cells
cell
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021226507A
Other languages
English (en)
Inventor
Xiaoping Bao
Yun Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Purdue Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation
Publication of AU2021226507A1 publication Critical patent/AU2021226507A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/148—Transforming growth factor alpha [TGF-a]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2021226507A 2020-02-28 2021-02-22 Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition Pending AU2021226507A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062982992P 2020-02-28 2020-02-28
US62/982,992 2020-02-28
PCT/US2021/018964 WO2021173458A1 (en) 2020-02-28 2021-02-22 Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition

Publications (1)

Publication Number Publication Date
AU2021226507A1 true AU2021226507A1 (en) 2022-09-01

Family

ID=77490309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021226507A Pending AU2021226507A1 (en) 2020-02-28 2021-02-22 Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition

Country Status (7)

Country Link
US (1) US20230097226A1 (https=)
EP (1) EP4110900A4 (https=)
JP (1) JP2023515579A (https=)
CN (1) CN115135754B (https=)
AU (1) AU2021226507A1 (https=)
CA (1) CA3171960A1 (https=)
WO (1) WO2021173458A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591381B2 (en) 2020-11-30 2023-02-28 Crispr Therapeutics Ag Gene-edited natural killer cells
WO2022144632A1 (en) 2020-12-30 2022-07-07 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into nk cells
JP2024531626A (ja) * 2021-09-10 2024-08-29 スンクワン メディカル ファウンデーション 分化全能性幹細胞由来の造血幹細胞の製造方法、及び製造された造血幹細胞を利用したヒト化マウスモデル作製方法
KR20240054468A (ko) * 2022-10-18 2024-04-26 의료법인 성광의료재단 줄기세포에서 대식세포로의 분화 유도용 배지 조성물 및 이를 이용한 분화 방법
CN120303395A (zh) * 2022-12-02 2025-07-11 安徽中盛溯源生物科技有限公司 用于分化多能干细胞的方法和组合物和衍生的造血谱系细胞

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080207594A1 (en) * 2005-05-04 2008-08-28 Davelogen Aktiengesellschaft Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders
CA2726164A1 (en) * 2008-05-27 2009-12-23 The Board Of Regents Of The University Of Texas System Wnt protein signalling inhibitors
WO2010033906A2 (en) * 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
KR101720961B1 (ko) * 2009-02-27 2017-03-29 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 다능성 세포의 분화
JP5777115B2 (ja) * 2010-03-18 2015-09-09 国立大学法人京都大学 多能性幹細胞から中胚葉細胞への分化誘導法
US9896659B2 (en) * 2011-10-19 2018-02-20 Stowers Institute For Medical Research Methods, kits, and compositions for stem cell self-renewal
WO2014078414A1 (en) * 2012-11-13 2014-05-22 Joseph Wu Chemically defined production of cardiomyocytes from pluripotent stem cells
CN106661553B (zh) * 2014-05-06 2020-09-01 豪夫迈·罗氏有限公司 用于使多能干细胞分化为心肌细胞的方法
AU2016211671B2 (en) * 2015-01-26 2022-05-26 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
US10669528B2 (en) * 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
CA3003152A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2017161001A1 (en) * 2016-03-15 2017-09-21 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion
WO2017193177A1 (en) * 2016-05-13 2017-11-16 Murdoch Childrens Research Institute Haematopoietic stem/progenitor cells
SG11202006731VA (en) * 2018-01-18 2020-08-28 Agency Science Tech & Res Method for differentiation of human pluripotent stem cell lines in suspension culture
CN108300695B (zh) * 2018-02-07 2021-08-06 清华大学 一种人类多能干细胞向造血干细胞分化的方法及培养添加剂
US12497593B2 (en) * 2018-09-07 2025-12-16 Wisconsin Alumni Research Foundation Generation of hematopoietic progenitor cells from human pluripotent stem cells

Also Published As

Publication number Publication date
EP4110900A1 (en) 2023-01-04
US20230097226A1 (en) 2023-03-30
CN115135754B (zh) 2026-01-20
CN115135754A (zh) 2022-09-30
JP2023515579A (ja) 2023-04-13
WO2021173458A1 (en) 2021-09-02
EP4110900A4 (en) 2024-04-24
CA3171960A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
JP6529541B2 (ja) 幹細胞よりナチュラルキラー細胞を発生させる方法
US20230097226A1 (en) Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition
US12497593B2 (en) Generation of hematopoietic progenitor cells from human pluripotent stem cells
EP3455344B1 (en) Haematopoietic stem/progenitor cells
CN107257852B (zh) 生成动脉内皮细胞群
JP2020124212A (ja) ヒト造血幹／前駆細胞のエクスビボ拡大のための組成物および方法
KR102861022B1 (ko) 조혈 이식체의 개선 방법
Tamaoki et al. Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells
JP2023540212A (ja) ヒト卵黄嚢様造血細胞を生成するための組成物および方法
AU2012313347A1 (en) Method for the ex vivo expansion of hematopoietic stem and progenitor cells
JP2024501449A (ja) ヒトキメラ抗原受容体好中球、組成物、キット、および使用の方法
Liang et al. Conversion of placental hemogenic endothelial cells to hematopoietic stem and progenitor cells
KR20250084950A (ko) 만능 세포에서 유래된 적혈구 계통
JP6861405B2 (ja) 造血系細胞の作製方法
Kim et al. Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model
KR102782318B1 (ko) 역분화 줄기세포에서 유래된 조혈모세포를 이용한 동물 모델의 제조
Marcoux RET-altered Induced Pluripotent Stem Cells (iPSCs) for modeling Hematopoiesis and Non-Small Cell Lung Cancer (NSCLC)
Mazurek et al. In vitro derivation of megakaryocytes and platelets from induced pluripotent stem cells: developmental foundations and translational perspectives
Bennett et al. Restraint of TGFβ family signaling by SMAD7 is necessary for hematopoietic stem cell maturation in the embryo
HK40017506A (en) Method for developing natural killer cells from stem cells